ImmunityBio
IBRX
IBRX
238 hedge funds and large institutions have $328M invested in ImmunityBio in 2025 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 102 increasing their positions, 37 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
238
Holders Change
+30
Holders Change %
+14.42%
% of All Funds
3.19%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
60
Increased
102
Reduced
37
Closed
26
Calls
$11.9M
Puts
$12.2M
Net Calls
-$313K
Net Calls Change
+$5.37M
Top Buyers
| 1 |
1
Bank of America
Charlotte,
North Carolina
|
$23.1M |
| 2 |
AC
2
Armistice Capital
New York
|
$20.5M |
| 3 |
3
Jane Street
New York
|
$20.4M |
| 4 |
4
BlackRock
New York
|
$46.9M |
| 5 |
AC
5
AlphaCore Capital
La Jolla,
California
|
$7.85M |
Top Sellers
| 1 |
1
Verition Fund Management
Greenwich,
Connecticut
|
$649K |
| 2 |
2
Group One Trading
Chicago,
Illinois
|
$2.05M |
| 3 |
HF
3
HRT Financial
New York
|
$0 |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$3.14M |
| 5 |
5
Citigroup
New York
|
$6.57M |
